128 related articles for article (PubMed ID: 6129338)
21. Parathyroid hormone (PTH) and PTH-related peptide induce relaxation of smooth muscle cells from guinea pig ileum: interaction with vasoactive intestinal peptide receptors.
Botella A; Rekik M; Delvaux M; Davicco MJ; Barlet JP; Frexinos J; Bueno L
Endocrinology; 1994 Nov; 135(5):2160-7. PubMed ID: 7525262
[TBL] [Abstract][Full Text] [Related]
22. The influence of vasoactive intestinal polypeptide and cholecystokinin on prolactin release in rat and human monolayer cultures.
Malarkey WB; O'Dorisio TM; Kennedy M; Cataland S
Life Sci; 1981 Jun; 28(22):2489-95. PubMed ID: 7253836
[No Abstract] [Full Text] [Related]
23. The opposite effects of central and peripheral vasoactive intestinal polypeptide on blood pressure in rats.
Casto R; Phillips MI
Neurosci Lett; 1983 Jul; 38(2):169-73. PubMed ID: 6621937
[TBL] [Abstract][Full Text] [Related]
24. Intracerebroventricular administration of vasoactive intestinal peptide inhibits food intake.
Ghourab S; Beale KE; Semjonous NM; Simpson KA; Martin NM; Ghatei MA; Bloom SR; Smith KL
Regul Pept; 2011 Dec; 172(1-3):8-15. PubMed ID: 21802451
[TBL] [Abstract][Full Text] [Related]
25. Vasoactive intestinal polypeptide stimulation of cyclic AMP formation in rat central nervous system.
Kaneko T; Nakaya S; Saito S; Yanaihara N; Oka H
Endocrinol Jpn; 1980 Dec; 27 Suppl 1():7-10. PubMed ID: 6112141
[TBL] [Abstract][Full Text] [Related]
26. Central effects of vasoactive intestinal polypeptide on intraocular pressure and body temperature in rabbits.
Moolchandani J; Krupin T
Curr Eye Res; 1987 Jul; 6(7):935-41. PubMed ID: 3621985
[TBL] [Abstract][Full Text] [Related]
27. Effect of vasoactive intestinal peptide on dopaminergic system in the rat brain.
Itoh S; Katsuura G; Takashima A
Peptides; 1988; 9(2):315-7. PubMed ID: 3375138
[TBL] [Abstract][Full Text] [Related]
28. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide.
Tanimoto K; Tamminga CA; Chase TN; Nilaver G
Endocrinology; 1987 Jul; 121(1):127-32. PubMed ID: 3297634
[TBL] [Abstract][Full Text] [Related]
29. Effect of intracerebroventricular injection of vasoactive intestinal polypeptide on systemic blood pressure and pancreatic and gastric secretions in the rat.
Mizuta K; Moriga M; Narusawa H; Uchino H; Aono M
Gastroenterol Jpn; 1986 Feb; 21(1):55-61. PubMed ID: 3699399
[TBL] [Abstract][Full Text] [Related]
30. Vasodilatory effects of vasoactive intestinal polypeptide (VIP) on isolated rat arteries.
Suzuki Y; Kobayashi Y; Lederis K
Proc West Pharmacol Soc; 1983; 26():341-4. PubMed ID: 6889362
[No Abstract] [Full Text] [Related]
31. Somatostatin action on insulin secretion induced by chicken and porcine vasoactive intestinal peptide in the perfused rat pancreas.
Arilla E; Prieto JC; López-Martínez JM; Goberna R
Horm Metab Res; 1981 Jun; 13(6):314-7. PubMed ID: 6114916
[TBL] [Abstract][Full Text] [Related]
32. Effect of vasoactive intestinal peptide (VIP) on somatostatin inhibition of pituitary growth hormone secretion in vitro.
Tapia-Arancibia L; Arancibia S; Bluet-Pajot MT; Enjalbert A; Epelbaum J; Priam M; Kordon C
Eur J Pharmacol; 1980 May; 63(2-3):235-6. PubMed ID: 6103817
[No Abstract] [Full Text] [Related]
33. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
Michalkiewicz M; Suzuki M; Kato M
Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
[TBL] [Abstract][Full Text] [Related]
34. Cholecystokinin-octapeptide suppresses stress-induced eating by inducing hyperglycemia.
Levine AS; Morley JE
Regul Pept; 1981 Nov; 2(6):353-7. PubMed ID: 6272376
[TBL] [Abstract][Full Text] [Related]
35. Efffect of vasoactive intestinal polypeptide on gallbladder smooth muscle in vitro.
Ryan JP; Ryave S
Am J Physiol; 1978 Jan; 234(1):E44-6. PubMed ID: 623247
[TBL] [Abstract][Full Text] [Related]
36. Effects of glucagon, secretin, and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomach.
Chiba T; Taminato T; Kadowaki S; Abe H; Chihara K; Seino Y; Matsukura S; Fujita T
Gastroenterology; 1980 Jul; 79(1):67-71. PubMed ID: 6103859
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus.
Matsuda K; Maruyama K; Nakamachi T; Miura T; Uchiyama M; Shioda S
Peptides; 2005 Sep; 26(9):1611-6. PubMed ID: 16112400
[TBL] [Abstract][Full Text] [Related]
38. Vasoactive intestinal polypeptide promotes sleep without effects on brain temperature in rats at night.
Obál F; Sáry G; Alföldi P; Rubicsek G; Obál F
Neurosci Lett; 1986 Feb; 64(2):236-40. PubMed ID: 3960403
[TBL] [Abstract][Full Text] [Related]
39. The interaction of vasoactive intestinal polypeptide (VIP), glucose and arginine on the secretion of insulin, glucagon and somatostatin in the perfused rat pancreas.
Szecówka J; Sandberg E; Efendić S
Diabetologia; 1980 Aug; 19(2):137-42. PubMed ID: 6106616
[TBL] [Abstract][Full Text] [Related]
40. Effects of gastrointestinal peptides on formation of gallstone in guinea pigs.
Chen YF; Chen YJ; Deng BA; Sun GN; Lu GJ; Pan GZ
Chin Med J (Engl); 1991 Apr; 104(4):277-80. PubMed ID: 1676624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
